The short answer
Valerian may cause mental dullness, but added sedation with ropinirole has not been measured. Review the combination with your pharmacist, especially if you already have daytime sleepiness or take other sedating medicines.
What this answer covers
Oral Valeriana officinalis root and rhizome products; mixtures and other species are not assumed equivalent.
- Supplement or preparation
- Valeriana officinalis
- Medication ingredient
- ropinirole
The concern is plausible but unmeasured
NCCIH describes valerian as possibly sleep-inducing and advises against taking it with sedatives or alcohol. Ropinirole can itself cause sleepiness. These warnings support a review, but do not quantify the risk of this exact combination.
A trial did not establish insomnia benefit
In a four-week trial, valerian did not improve the primary insomnia outcome more than placebo. Participants were not studied as a ropinirole interaction group, and the result does not prove the combination safe.
Review ongoing use and the complete product
Show your pharmacist the ingredient list and how long you have used valerian. Long-term safety is uncertain, and withdrawal symptoms have been reported after abrupt stopping with chronic use. Plan changes with the treating team; no protective spacing interval is established.
When daytime sleepiness needs attention
Contact your prescriber promptly for new marked daytime sleepiness or falling asleep during ordinary activities. Do not drive or use machinery if this occurs. Ropinirole can cause sleep episodes even without a warning feeling of drowsiness; the treating team should decide how to change treatment.
Evidence and practical considerations
Side effects & toxicity
Possible impairment supports caution, without demonstrating additive ropinirole toxicity.
- Exact scope
- Oral Valeriana officinalis root and rhizome products; mixtures and other species are not assumed equivalent. with Oral immediate-release ropinirole, with hydrochloride salt expressed as equivalent free base in label section 11.
- Medication form and route
- oral
- Timing or duration
- No exact-pair safe duration or protective spacing interval established.
What remains uncertain
- Valerian guidance describes sleep-inducing effects as possible rather than proven; no exact-pair controlled trial identified.
Factors that may matter: baseline alertness; exact preparation; other medicines; treatment indication.
Read the supporting source summaries
Source 1: current product label
dailymed.nlm.nih.gov · Source check Sep 10, 2026
Population: People prescribed oral immediate-release ropinirole tablets for Parkinson disease or primary restless legs syndrome.
Ropinirole can cause somnolence, sudden sleep episodes and orthostatic hypotension. Concomitant sedating medicines or alcohol can increase sleepiness risk. CYP1A2 is its major metabolic enzyme; inhibitors and inducers may alter clearance. Ciprofloxacin increased exposure, whereas theophylline did not. Cigarette smokers had lower dose-normalized exposure than nonsmokers in a small RLS comparison.
How this applies: Exact oral ropinirole risk and metabolic context; section 11 justifies hydrochloride-to-free-base active-moiety identity only.
No direct study of these six supplement combinations. Immediate-release tablet context does not establish release-form or dose interchangeability.
Source 2: official guidance
nccih.nih.gov · Source check Sep 10, 2026
Population: People considering the specified supplement.
Possible but unproven sleep-inducing effect; advises against use with alcohol or sedatives. Mental dullness can occur; long-term safety is uncertain.
How this applies: Preparation-specific context; not a directly measured ropinirole interaction.
No ropinirole interaction trial. Chronic use can be followed by withdrawal symptoms when stopped abruptly.
Source 3: randomized placebo-controlled trial
pubmed.ncbi.nlm.nih.gov · Source check Sep 10, 2026
Population: 391 adults randomized to three groups in an internet-based trial.
Neither active intervention improved its primary anxiety or insomnia outcome more than placebo.
How this applies: Preparation-specific context; not a directly measured ropinirole interaction.
Not both active botanicals together, not ropinirole co-use. Accessible abstract does not fully characterize dose and preparation; efficacy result is not proof of combination safety.
Research assessment: · Open full citations ↗
Review and change history
- Publication status
- Published research summary
- Clinical review
- Not yet recorded
| Date | Update |
|---|---|
| Article prepared | |
| Targeted sources inspected and all current available claims adjudicated; no clinical review asserted. | |
| Research summary published |
Article revision: 537fdd3cb41a47b2
This guide brings together the evidence records used by our interaction checker. Each finding retains its own preparation limits, research date, and source summaries.
Full citations require verification. Reading this answer and the source summaries does not.
Taking other supplements or medications?
Use the checker to explore your other combinations. Ask a pharmacist to review the exact products, amounts and medical conditions in your complete list.
Open the interaction checkerInformation, not medical advice. Do not change prescribed treatment based on this guide.